Arias-Pulido, Hugo http://orcid.org/0000-0003-4941-1110
Cimino-Mathews, Ashley Marie
Chaher, Nabila
Qualls, Clifford Ray
Joste, Nancy
Colpaert, Cecile
Marotti, Jonathan Douglas
Chamberlin, Mary Dickinson
Foisey, Maxwell Gabriel
Prossnitz, Eric Robert
Emens, Leisha Ann
Fiering, Steven
Funding for this research was provided by:
GlaxoSmithKline (No number)
International Union Against Cancer (ICR/09/0443)
Foundation for the National Institutes of Health (CA163890, CA194496, R01CA224605)
Article History
Received: 4 June 2021
Accepted: 6 September 2021
First Online: 20 September 2021
Declarations
:
: LAE receives honoraria and research funding to the institution from Aduro Biotech, Astrazeneca, Bristol Meyers Squibb, Corvus, EMD Serono, Genentech, HeritX, Inc., Maxcyte, Merck, Roche, Tempest; and royalties from Aduro Biotech. She has served on Consulting/Advisory boards for AbbVie, Amgen, Astrazeneca, Bayer, Bristol Meyers Squibb, Celgene, Chugai, eTHeRNA, Genentech, Gritstone, Medimmune, Molecuvax, Macrogenics, Novartis, Peregrine, Replimune, Roche, Silverback, Syndax, Vaccinex. ACM receives honoraria from Bristol-Myers Squibb and Roche and research funding to the institution from Bristol-Myers Squibb, Genentech, and HeritX, Inc. Dr. Fiering is a co-founder of and has a financial interest in Mosaic Immunoengineering Inc. The remaining authors declare no conflict of interest.
: This observational retrospective study involving human participants was approved by the Committee for the Protection of Human Subjects at Dartmouth College (STUDY00029655). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Formal patient consent for studies using anonymous human specimens is not required.